FDA recommends authorizing Pfizer COVID-19 vaccine for use in 5-11 age group

A Food and Drug Administration advisory committee today voted to recommend an emergency use authorization of Pfizer’s COVID-19 vaccine for children age 5-11. The agency’s Vaccines and Related Biological Products Advisory Committee, by a 17-1 vote, agreed that the available evidence justifies the administration of two 10-microgram doses, administered three weeks apart, particularly among those at the highest risk of severe COVID-19.
Related News Articles
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…